Flu-v - oven ready4 May 2020 15:40
for final safety test.. Acts by stimulating an immune response mediated through T-cells and B-cells that recognise infected cells and destroy them, in contrast to seasonal influenza vaccines that prevent infection through antibody protection against external proteins.
Two Phase IIb studies have achieved primary endpoints:
field study, FLU-v 003; and
challenge study, FLU-v 004.
Took over the company a few weeks before the world changed forever. And Cathal knows it.